Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N‑({4‑[(2‑aminopyridin‑4‑yl)oxy]‑3‑fluorophenyl}carbamoyl)‑2‑(4‑fluorophenyl)acetamide is a synthetic small molecule belonging to the class of n-acyl phenylureas. It has been described in chemical and patent literature as an experimental compound, with no approved therapeutic use or established clinical indication. The compound is referenced in medicinal chemistry research and patents related to kinase inhibition, particularly as a potential Aurora kinase inhibitor for cancer therapy, but there is no evidence of advanced clinical development or commercial availability[1][5][6]. Its precise mechanism of action and biological targets are not fully characterized in public databases.
- Other names
- 1-{4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}-3-[2-(4-fluorophenyl)acetyl]urea3-{4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}-1-[2-(4-fluorophenyl)acetyl]ureaN-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenyl)-5-benzyl
Beyond the preview
Go deeper on N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide.